Pattern recognition receptor responses in children with chronic hepatitis B virus infection

Journal of Clinical Virology

Volumn 54, Issue 3, 2012, Pages 229-234

  Heiberg, Ida Louise ^a   Winther, Thilde Nordmann ^a   Paludan, Søren Riis ^b   Hogh, Birthe ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Children; Cytosolic DNA receptor; Hepatitis B virus; Toll like receptor

Indexed keywords

ALPHA INTERFERON; DNA; DOUBLE STRANDED DNA; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; LIPOFECTAMINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFANT; INTERFERON PRODUCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSOR; SUPERNATANT;

ADOLESCENT; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CYTOKINES; DNA; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT; LEUKOCYTES, MONONUCLEAR; MALE; RECEPTORS, PATTERN RECOGNITION; TRANSFECTION;

EID: 84861656418     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.04.013     Document Type: Article

References (29)

1. Durantel D., Zoulim F. Innate response to hepatitis B virus infection: observations challenging the concept of a stealth virus. Hepatology 2009, 50(December (6)):1692-1695.
2. Das A., Maini M.K. Innate and adaptive immune responses in hepatitis B virus infection. Dig Dis 2010, 28(1):126-132.
3. Bertoletti A., Gehring A.J. The immune response during hepatitis B virus infection. J Gen Virol 2006, 87(June (Pt 6)):1439-1449.
4. Mogensen T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009, 22(April (2)):240-273. [table].
5. Rasmussen S.B., Reinert L.S., Paludan S.R. Innate recognition of intracellular pathogens: detection and activation of the first line of defense. APMIS 2009, 117(May (5-6)):323-337.
6. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11(May (5)):373-384.
7. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010, 11(November (11)):997-1004.
8. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448(July (7152)):501-505.
9. Chen Z., Cheng Y., Xu Y., Liao J., Zhang X., Hu Y., et al. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clin Immunol 2008, 128(September (3)):400-408.
10. Riordan S.M., Skinner N., Kurtovic J., Locarnini S., Visvanathan K. Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B. Clin Vaccine Immunol 2006, 13(August (8)):972-974.
11. Visvanathan K., Skinner N.A., Thompson A.J., Riordan S.M., Sozzi V., Edwards R., et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007, 45(January (1)):102-110.
12. Zhang Y., Lian J.Q., Huang C.X., Wang J.P., Wei X., Nan X.P., et al. Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection. Virology 2010, 397(February (1)):34-42.
13. Xie Q., Shen H.C., Jia N.N., Wang H., Lin L.Y., An B.Y., et al. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect 2009, 11(April (4)):515-523.
14. Davis A.R., Rosenthal P., Hepatitis B. in children. Pediatr Rev 2008, 29(April (4)):111-119.
15. Ni Y.H. Natural history of hepatitis B virus infection: pediatric perspective. J Gastroenterol 2011, 46(January (1)):1-8.
16. Mikkelsen S.S., Jensen S.B., Chiliveru S., Melchjorsen J., Julkunen I., Gaestel M., et al. RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1. J Biol Chem 2009, 284(April (16)):10774-10782.
17. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284(April (5415)):825-829.
18. Kuo T.M., Hu C.P., Chen Y.L., Hong M.H., Jeng K.S., Liang C.C., et al. HBV replication is significantly reduced by IL-6. J Biomed Sci 2009, 16:41.
19. Kakumu S., Shinagawa T., Ishikawa T., Yoshioka K., Wakita T., Ida N. Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis. Gastroenterol Jpn 1993, 28(February (1)):18-24.
20. Tangkijvanich P., Vimolket T., Theamboonlers A., Kullavanijaya P., Suwangool P., Poovorawan Y. Serum interleukin-6 and interferon-gamma levels in patients with hepatitis B-associated chronic liver disease. Asian Pac J Allergy Immunol 2000, 18(June (2)):109-114.
21. Liu Q., Feng G.X., Lin Y.L., Peng Y.Z., Mo B.Q. Detection of interleukin-6 and -12 in of hepatitis B patients and its clinical significance. Acad J Med Coll PLA 2001, 21(11):858-859.
22. Song L.H., Binh V.Q., Duy D.N., Kun J.F., Bock T.C., Kremsner P.G., et al. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 2003, 28(September (1)):93-103.
23. Puro R., Schneider R.J. Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J Virol 2007, 81(July (14)):7351-7362.
24. Liu Y.Q., Poon R.T., Hughes J., Li Q.Y., Yu W.C., Fan S.T. Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma. World J Gastroenterol 2005, 11(January (2)):164-170.
25. Lu P., Nakamoto Y., Nemoto-Sasaki Y., Fujii C., Wang H., Hashii M., et al. Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. Am J Pathol 2003, 162(April (4)):1249-1258.
26. Yang X., Lu P., Fujii C., Nakamoto Y., Gao J.L., Kaneko S., et al. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression. Int J Cancer 2006, 118(April (8)):1869-1876.
27. Wei X.Q., Guo Y.W., Liu J.J., Wen Z.F., Yang S.J., Yao J.L. The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B. Clin Invest Med 2008, 31(3):E123-E130.
28. Woltman A.M., Op den Brouw M.L., Biesta P.J., Shi C.C., Janssen H.L. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS ONE 2011, 6(1):e15324.
29. Xu Y., Hu Y., Shi B., Zhang X., Wang J., Zhang Z., et al. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 2009, 46(August (13)):2640-2646.